Cathie Wood’s Sell-Off in SRTA Reflects a Bet Against Traditional Medical Devices in an AI-Driven Future

Cathie Wood sold 180,000 shares of Strata Critical Medical (SRTA.US) on April 13. SRTA manufactures traditional intensive care medical devices. Traditional ICU devices lack data-driven capabilities. Without data collection capacity, medical devices cannot integrate with generative AI systems. Cathie Wood envisions medical devices as data terminals for large-scale AI models. Devices that cannot feed AI models have diminished development potential in Wood’s investment framework. SRTA’s exclusion from AI synergy reduces its long-term growth outlook in ARK Invest’s portfolio strategy.